355423-58-4

Basic information

• Product Name: 6-BroMo-7-fluoro-2,4-dihydro-1,4-benzoxazin-3-one
• Synonyms: 6-BroMo-7-fluoro-2,4-dihydro-1,4-benzoxazin-3-one;6-bromo-7-fluoro-2H-benzo[b][1,4]oxazin-3(4H)-one;6-Bromo-7-fluoro-4H-benzo[1,4]oxazin-3-one
• CAS NO: 355423-58-4
• Molecular Formula: C8H5BrFNO2
• Molecular Weight: 246.0332032
• Mol File: 355423-58-4.mol
• Article Data: 1

Chemical Properties

• Appearance: /Solid
• CAS DataBase Reference: 6-BroMo-7-fluoro-2,4-dihydro-1,4-benzoxazin-3-one(CAS DataBase Reference)
• NIST Chemistry Reference: 6-BroMo-7-fluoro-2,4-dihydro-1,4-benzoxazin-3-one(355423-58-4)
• EPA Substance Registry System: 6-BroMo-7-fluoro-2,4-dihydro-1,4-benzoxazin-3-one(355423-58-4)

Safety Data

• Hazardous Substances Data: 355423-58-4(Hazardous Substances Data)

Upstream product

• 103361-99-5 7-fluoro-3,4-dihydro-3-oxo-2H-1,4-benzoxazine 

Downstream Products

• 1160102-28-2 6-bromo-7-fluoro-3,4-dihydro-2H-benzo[b][1,4]oxazine 

Relevant articles and documents

FUSED THIAZOLE AND THIOPHENE DERIVATIVES AS KINASE INHIBITORS

A series of fused bicyclic thiazole and thiophene derivatives which are substituted in the 2-position by an optionally substituted morpholin-4-yl moiety, and in the 4-position by hydroxy, oxo or an amine moiety, being selective inhibitors of PI3 kinase enzymes, are accordingly of benefit in medicine, for example in the treatment of inflammatory, autoimmune, cardiovascular, neurodegenerative, metabolic, oncological, nociceptive or ophthalmic conditions. (I)